Genenta Science (GNTA) Fundamental Analysis: Revenue, Earnings & Valuation

1.88 / 10

Underperform

Fundamental analysis rates GNTA as Underperform with a 1.9/10 score. Inventory turnover (37.77) and fixed‑asset turnover (1017.9) are modest positives, while gross profit margin (38.37%) and income‑tax ratio (0%) are weak. Overall, financial health appears challenged.

Analysis Checks(3/6)

Total operating revenue (YoY growth rate %)

Value292.23

Score1/3

Weight36.51%

1M Return-3.06%

Inventory turnover ratio

Value37.77

Score2/3

Weight14.38%

1M Return-1.21%

Gross profit margin (%)

Value38.37

Score1/3

Weight7.25%

1M Return-0.63%

Income tax / Total profit (%)

Value0.00

Score1/3

Weight5.90%

1M Return-0.50%

Fixed assets turnover ratio

Value1017.92

Score3/3

Weight-13.18%

1M Return1.06%

Cost of sales ratio (%)

Value73.08

Score2/3

Weight49.13%

1M Return-4.42%

Is GNTA undervalued or overvalued?

GNTA scores 1.88/10 on fundamentals and holds a Premium valuation at present. Backed by its -38.03% ROE, 0.00% net margin, -2.06 P/E ratio, 0.62 P/B ratio, and 23.64% earnings growth, these metrics solidify its Underperform investment rating.